Literature DB >> 9013047

Early and middle latency evoked potentials in medically and psychiatrically normal daily marihuana users: a paucity of significant findings.

G Patrick1, J J Straumanis, F A Struve, M J Fitz-Gerald, J E Manno.   

Abstract

The use of evoked potentials to study CNS effects of marihuana (THC) have produced inconsistent findings. Our previous pilot studies suggested that auditory P300 latencies and amplitudes, auditory P50 and somatosensory P30 amplitudes and brainstem auditory evoked potential latencies were altered in THC users. Because these findings were flawed by uncontrolled psychiatric diagnostic and medication variables, we undertook a controlled investigation of screened medically and psychiatrically normal THC users and controls. When age effects were controlled, THC related alterations of brain stem and both auditory and visual P300 responses could not be seen. This report extends our analyses to other auditory, somatosensory and visual evoked potentials. With the possible exception of an elevated auditory P50 amplitude, significant evoked potential correlates to daily THC use were not seen when normals were studied and age effects controlled.

Entities:  

Mesh:

Year:  1997        PMID: 9013047     DOI: 10.1177/155005949702800105

Source DB:  PubMed          Journal:  Clin Electroencephalogr        ISSN: 0009-9155


  7 in total

1.  Transdermal nicotine administration and the electroencephalographic activity of substance abusers in treatment.

Authors:  Natalie A Ceballos; Rick Tivis; Robert Prather; Sara Jo Nixon
Journal:  J Addict Med       Date:  2008       Impact factor: 3.702

2.  Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.

Authors:  Johannes Rentzsch; Ada Stadtmann; Christiane Montag; Hagen Kunte; Doris Plöckl; Rainer Hellweg; Jürgen Gallinat; Golo Kronenberg; Maria Christiane Jockers-Scherübl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-17       Impact factor: 5.270

3.  Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans.

Authors:  Adam B Steinmetz; Chad R Edwards; Jennifer M Vollmer; Molly A Erickson; Brian F O'Donnell; William P Hetrick; Patrick D Skosnik
Journal:  Psychopharmacology (Berl)       Date:  2011-12-02       Impact factor: 4.530

Review 4.  Residual neuropsychologic effects of cannabis.

Authors:  H G Pope; A J Gruber; D Yurgelun-Todd
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

5.  Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

Authors:  Deepak Cyril D'Souza; Daniel J Fridberg; Patrick D Skosnik; Ashley Williams; Brian Roach; Nagendra Singh; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Brian Pittman; R Andrew Sewell; Mohini Ranganathan; Daniel Mathalon
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

6.  Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning.

Authors:  Patrick D Skosnik; Chad R Edwards; Brian F O'Donnell; Ashley Steffen; Joseph E Steinmetz; William P Hetrick
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

Review 7.  EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research.

Authors:  Tato M Sokhadze; Rex L Cannon; David L Trudeau
Journal:  Appl Psychophysiol Biofeedback       Date:  2008-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.